175 related articles for article (PubMed ID: 9751750)
1. Expression and crystallization of the complex of HLA-DR2 (DRA, DRB1*1501) and an immunodominant peptide of human myelin basic protein.
Gauthier L; Smith KJ; Pyrdol J; Kalandadze A; Strominger JL; Wiley DC; Wucherpfennig KW
Proc Natl Acad Sci U S A; 1998 Sep; 95(20):11828-33. PubMed ID: 9751750
[TBL] [Abstract][Full Text] [Related]
2. Visualization of myelin basic protein (MBP) T cell epitopes in multiple sclerosis lesions using a monoclonal antibody specific for the human histocompatibility leukocyte antigen (HLA)-DR2-MBP 85-99 complex.
Krogsgaard M; Wucherpfennig KW; Cannella B; Hansen BE; Svejgaard A; Pyrdol J; Ditzel H; Raine C; Engberg J; Fugger L
J Exp Med; 2000 Apr; 191(8):1395-412. PubMed ID: 10770805
[TBL] [Abstract][Full Text] [Related]
3. Structural requirements for binding of an immunodominant myelin basic protein peptide to DR2 isotypes and for its recognition by human T cell clones.
Wucherpfennig KW; Sette A; Southwood S; Oseroff C; Matsui M; Strominger JL; Hafler DA
J Exp Med; 1994 Jan; 179(1):279-90. PubMed ID: 7505801
[TBL] [Abstract][Full Text] [Related]
4. Design, engineering, and production of human recombinant t cell receptor ligands derived from human leukocyte antigen DR2.
Chang JW; Mechling DE; Bächinger HP; Burrows GG
J Biol Chem; 2001 Jun; 276(26):24170-6. PubMed ID: 11319230
[TBL] [Abstract][Full Text] [Related]
5. Expression of recombinant HLA-DR2 molecules. Replacement of the hydrophobic transmembrane region by a leucine zipper dimerization motif allows the assembly and secretion of soluble DR alpha beta heterodimers.
Kalandadze A; Galleno M; Foncerrada L; Strominger JL; Wucherpfennig KW
J Biol Chem; 1996 Aug; 271(33):20156-62. PubMed ID: 8702739
[TBL] [Abstract][Full Text] [Related]
6. Structural basis for the binding of an immunodominant peptide from myelin basic protein in different registers by two HLA-DR2 proteins.
Li Y; Li H; Martin R; Mariuzza RA
J Mol Biol; 2000 Nov; 304(2):177-88. PubMed ID: 11080454
[TBL] [Abstract][Full Text] [Related]
7. A humanized model for multiple sclerosis using HLA-DR2 and a human T-cell receptor.
Madsen LS; Andersson EC; Jansson L; krogsgaard M; Andersen CB; Engberg J; Strominger JL; Svejgaard A; Hjorth JP; Holmdahl R; Wucherpfennig KW; Fugger L
Nat Genet; 1999 Nov; 23(3):343-7. PubMed ID: 10610182
[TBL] [Abstract][Full Text] [Related]
8. Restricted TCR Valpha gene rearrangements in T cells recognizing an immunodominant peptide of myelin basic protein in DR2 patients with multiple sclerosis.
Zang YC; Kozovska M; Aebischer I; Li S; Boehme S; Crowe P; Rivera VM; Zhang JZ
Int Immunol; 1998 Jul; 10(7):991-8. PubMed ID: 9701037
[TBL] [Abstract][Full Text] [Related]
9. T cell response to myelin basic protein in the context of the multiple sclerosis-associated HLA-DR15 haplotype: peptide binding, immunodominance and effector functions of T cells.
Vergelli M; Kalbus M; Rojo SC; Hemmer B; Kalbacher H; Tranquill L; Beck H; McFarland HF; De Mars R; Long EO; Martin R
J Neuroimmunol; 1997 Aug; 77(2):195-203. PubMed ID: 9258250
[TBL] [Abstract][Full Text] [Related]
10. Crystal structure of HLA-DR2 (DRA*0101, DRB1*1501) complexed with a peptide from human myelin basic protein.
Smith KJ; Pyrdol J; Gauthier L; Wiley DC; Wucherpfennig KW
J Exp Med; 1998 Oct; 188(8):1511-20. PubMed ID: 9782128
[TBL] [Abstract][Full Text] [Related]
11. Structure of human T-cell receptors specific for an immunodominant myelin basic protein peptide: positioning of T-cell receptors on HLA-DR2/peptide complexes.
Wucherpfennig KW; Hafler DA; Strominger JL
Proc Natl Acad Sci U S A; 1995 Sep; 92(19):8896-900. PubMed ID: 7568039
[TBL] [Abstract][Full Text] [Related]
12. pH dependent binding of high and low affinity myelin basic protein peptides to purified HLA-DR2.
Mukku PV; Passmore D; Phan D; Nag B
Mol Immunol; 1995 Jun; 32(8):555-64. PubMed ID: 7541890
[TBL] [Abstract][Full Text] [Related]
13. Kinetics of T-cell receptor binding by bivalent HLA-DR. Peptide complexes that activate antigen-specific human T-cells.
Appel H; Gauthier L; Pyrdol J; Wucherpfennig KW
J Biol Chem; 2000 Jan; 275(1):312-21. PubMed ID: 10617620
[TBL] [Abstract][Full Text] [Related]
14. Recognition of the immunodominant myelin basic protein peptide by autoantibodies and HLA-DR2-restricted T cell clones from multiple sclerosis patients. Identity of key contact residues in the B-cell and T-cell epitopes.
Wucherpfennig KW; Catz I; Hausmann S; Strominger JL; Steinman L; Warren KG
J Clin Invest; 1997 Sep; 100(5):1114-22. PubMed ID: 9276728
[TBL] [Abstract][Full Text] [Related]
15. Redirecting therapeutic T cells against myelin-specific T lymphocytes using a humanized myelin basic protein-HLA-DR2-zeta chimeric receptor.
Moisini I; Nguyen P; Fugger L; Geiger TL
J Immunol; 2008 Mar; 180(5):3601-11. PubMed ID: 18292588
[TBL] [Abstract][Full Text] [Related]
16. Synthetic peptides that inhibit binding of the myelin basic protein 85-99 epitope to multiple sclerosis-associated HLA-DR2 molecules and MBP-specific T-cell responses.
Fridkis-Hareli M; Stern JN; Fugger L; Strominger JL
Hum Immunol; 2001 Aug; 62(8):753-63. PubMed ID: 11476898
[TBL] [Abstract][Full Text] [Related]
17. Naturally processed HLA class II peptides reveal highly conserved immunogenic flanking region sequence preferences that reflect antigen processing rather than peptide-MHC interactions.
Godkin AJ; Smith KJ; Willis A; Tejada-Simon MV; Zhang J; Elliott T; Hill AV
J Immunol; 2001 Jun; 166(11):6720-7. PubMed ID: 11359828
[TBL] [Abstract][Full Text] [Related]
18. Anergy induction by dimeric TCR ligands.
Appel H; Seth NP; Gauthier L; Wucherpfennig KW
J Immunol; 2001 Apr; 166(8):5279-85. PubMed ID: 11290814
[TBL] [Abstract][Full Text] [Related]
19. Functionally active recombinant alpha and beta chain-peptide complexes of human major histocompatibility class II molecules.
Nag B; Arimilli S; Mukku PV; Astafieva I
J Biol Chem; 1996 Apr; 271(17):10413-8. PubMed ID: 8626615
[TBL] [Abstract][Full Text] [Related]
20. Myelin autoreactivity in multiple sclerosis: recognition of myelin basic protein in the context of HLA-DR2 products by T lymphocytes of multiple-sclerosis patients and healthy donors.
Pette M; Fujita K; Wilkinson D; Altmann DM; Trowsdale J; Giegerich G; Hinkkanen A; Epplen JT; Kappos L; Wekerle H
Proc Natl Acad Sci U S A; 1990 Oct; 87(20):7968-72. PubMed ID: 1700423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
